Passing TAMC/TYMC Isn't Enough: The USP <62> Gap That Gets Herbal Supplement Brands in Trouble

A ginger root powder arrived at a Midwest supplement facility last year with a supplier COA showing TAMC at 820 CFU/g — comfortably below the 10,000 CFU/g limit the supplier cited. The QA team signed off. Four weeks into production, a retail customer complaint triggered a finished-product screen. The result: E. coli detected in one batch. The root cause traced back to that same ginger lot, which had been accepted without any testing for specified organisms. No one had asked the supplier for USP <62> data. Nobody caught the gap — not until it was very expensive.

That scenario isn’t a cautionary tale we invented. It’s a pattern documented in FDA warning letters and cGMP inspection reports year after year, and it reflects a persistent misunderstanding of what the USP microbiological testing framework actually requires of herbal supplement brands.

USP <61> and USP <62> Are Not the Same Test — Even When They’re Listed Together

Every accredited analytical testing laboratory familiar with dietary supplement microbiology will run both chapters. But they measure fundamentally different things, and conflating them is precisely where brands run into trouble.

USP <61> is the Microbial Enumeration Test. It counts. Specifically, it quantifies the total aerobic microbial count (TAMC) and total yeast and mold count (TYMC) in colony-forming units per gram (CFU/g). If your botanical powder comes back at 500 CFU/g TAMC and 80 CFU/g TYMC, USP <61> tells you the overall population density of viable microorganisms. That’s useful — it tells you whether a material was stored improperly, processed in a contaminated environment, or exposed to excessive moisture. But it doesn’t tell you which organisms are present.

USP <62> is the Test for Specified Microorganisms. It runs a series of absence/presence assays designed to detect specific pathogens and indicator organisms, regardless of what the total count shows. A botanical powder can carry Salmonella at concentrations too low to meaningfully affect TAMC — well below any enumeration threshold — and still pose a serious public health risk and a product liability exposure that no Midwest supplement brand wants to absorb.

That’s the USP <62> gap. And it’s disproportionately acute for brands sourcing herbal botanical raw materials.

Why Botanical Powders Fail USP <62> More Than Any Other Supplement Input

Botanical raw materials have a fundamentally different contamination profile than synthesized compounds or excipients manufactured under controlled conditions. They come from the field. They’re root-harvested, bark-stripped, berry-picked, or leaf-dried in environments with direct and sustained exposure to soil, irrigation water, wildlife, and ambient air. That environmental history doesn’t disappear when the material gets dried and milled into a powder.

Consider some of the most common adaptogens and functional botanicals used by Chicago-area brands:

• Ginger and turmeric roots are rhizomes — they grow underground in direct contact with soil. Agricultural soil is a primary environmental reservoir for E. coli and bile-tolerant gram-negative bacteria, particularly in regions where animal-based fertilizers or open irrigation systems are used.
• Elderberry, harvested in open orchards, sees significant bird activity throughout the growing season. Bird droppings are a well-documented vector for Salmonella, and orchard environments are difficult to control from any meaningful GMP standpoint.
• Ashwagandha root undergoes extensive drying and processing before export, but post-processing handling — rebagging, transshipment, repackaging at distribution hubs — can introduce Staphylococcus aureus through incidental personnel contact.
• Maca root powder, commonly imported from Peru, has appeared in multiple FDA import alerts due to elevated microbial contamination, including bile-tolerant gram-negatives that passed through origin-country testing undetected.

Low water activity (Aw) in dried powders does not sterilize — it suppresses growth. Salmonella is notably desiccation-tolerant and has been shown in peer-reviewed studies to remain viable in dried botanical matrices for 12 months or longer at ambient storage temperatures. A supplier who tested a production lot at origin and shipped it five months later may be handing you a COA that no longer reflects the material’s current microbial status. And a TAMC result on arrival tells you nothing about whether Salmonella is dormant in that lot.

What USP <62> Actually Requires — and the “Objectionable Organisms” Concept Most QA Teams Miss

For oral dietary supplements and their raw material inputs, the specified organism requirements under USP <62>, read alongside the acceptance criteria in USP <2021> and <2022>, typically include:

• Absence of Salmonella in 10 g (via selective enrichment, ISO 6579-equivalent protocols)
• Absence of Escherichia coli in 1 g
• Bile-tolerant gram-negative bacteria: absent in 1 g for most botanical categories
• Absence of Staphylococcus aureus in 1 g for certain product types
• Absence of Candida albicans in 1 g for some oral solid dosage forms

The exact panel depends on the material’s category classification and intended use. But for virtually any botanical raw material destined for an oral supplement, Salmonella and E. coli absence testing under USP <62> should be non-negotiable.

There’s also a concept embedded in USP <62> that doesn’t get enough attention in supplier qualification discussions: objectionable organisms. USP’s guidance is explicit that organisms not on the specified list can still be unacceptable if, given the route of administration, the patient population, or the product’s intended use, their presence could cause harm. This is a professional judgment requirement. It means QA teams and their testing partners can’t simply run the standard panel, get clean results, and stop thinking. If a botanical powder shows unusual gram-negative rods on direct microscopy that don’t resolve cleanly on the standard panel, that warrants follow-up. An experienced analytical testing laboratory will flag it. A commodity testing house may not.

Under FDA 21 CFR Part 111.70(b), dietary supplement manufacturers must establish specifications for each component — including raw materials — that include limits for any microbiological contamination that could adulterate the finished product. Under 21 CFR Part 111.75(a)(1), a representative sample from each received lot must be tested. “My supplier provided a COA” does not satisfy this requirement unless the testing was performed by a qualified lab on the specific lot you are receiving. Skip-lot acceptance is not compliant for incoming raw material identity and purity verification under current cGMP.

What a Complete Microbiology Package From an Accredited Analytical Testing Laboratory Looks Like

An accredited analytical testing laboratory running a proper dietary supplement microbiology panel for botanical raw materials should deliver all of the following on the Certificate of Analysis:

1. TAMC result in CFU/g, method cited as USP <61>
2. TYMC result in CFU/g, method cited as USP <61>
3. E. coli absence/presence in 1 g, method cited as USP <62>
4. Salmonella absence/presence in 10 g, method cited as USP <62>
5. Bile-tolerant gram-negative bacteria result with method reference
6. Lab name, ISO 17025 accreditation number and scope of accreditation, analyst signature, and lot-specific sampling traceability

Some materials warrant additional testing — Clostridium spp. for anaerobic-risk materials, Pseudomonas aeruginosa for botanicals that may contact mucous membranes, or total enterobacteria counts for materials with complex soil-contact histories. Your contract testing partner should advise you on which panel is appropriate for each specific material. Defaulting to the shortest available panel is a cost optimization that routinely produces compliance problems downstream.

ISO 17025 accreditation matters here because it confirms the lab’s microbiological methods have been independently validated and are subject to ongoing inter-laboratory proficiency testing. A COA from a non-accredited testing facility isn’t worthless, but it doesn’t carry the same defensibility in an FDA inspection or a third-party customer audit.

At our Chicago sample receiving facility, we routinely see botanical raw materials arrive with supplier COAs that document TAMC/TYMC and nothing else. When we run USP <62> panels on those same lots, the rate of specified organism findings is higher than most QA directors would expect. Elderberry lots, in particular, have a sobering track record in our receiving log.

What to Put in Your Supplier COA Requirements Today

If your current supplier qualification process accepts any botanical COA that shows TAMC/TYMC without specified organism data, that’s a corrective action worth opening now, before your next incoming lot arrives. Here’s the minimum standard for what a complete incoming botanical raw material microbiology COA should document:

• TAMC and TYMC results with method reference (USP <61>)
• E. coli absence in 1 g (USP <62>)
• Salmonella absence in 10 g (USP <62>)
• Bile-tolerant gram-negative bacteria absence in 1 g (USP <62>)
• Name and ISO 17025 accreditation number of the testing laboratory
• Test date and lot-specific sampling traceability
• Confirmation that testing was performed on this specific received lot — not on a retained reference sample or a representative sample from a different production batch

If a supplier can’t provide this, or if the COA lists only in-house testing with no ISO 17025 accreditation scope, request independent third-party verification before accepting the lot. A botanical microbiology panel at an accredited analytical testing laboratory typically runs under $350 for a standard specified-organism panel. Industry data from recall insurance carriers consistently places the average direct cost of a food and supplement recall above $8 million for a mid-size brand — accounting for regulatory response, product destruction, retail partner notifications, and customer remediation.

The math doesn’t support skipping the $350 test. And the ginger lot mentioned above — the one that cleared TAMC/TYMC and triggered an E. coli finding in finished product — generated well over $400,000 in direct investigation, disposal, and customer notification costs for a brand with a single SKU. All of it traceable back to one missing line on a supplier COA.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025 Accredited Supplement Testing — Qalitex Laboratories — Full-scope dietary supplement testing including USP <61>/<62> microbiology, ICP-MS heavy metals, and botanical identity, performed under ISO 17025 accreditation in California.
• Raw Material and Finished Product CoA Services — Qalitex — How Qalitex’s accredited lab generates defensible Certificates of Analysis for supplement manufacturers requiring FDA cGMP compliance documentation.